Necitumumab
Necitumumab | |
---|---|
Term | Necitumumab |
Short definition | necitumumab - (pronounced) (NEH-sih-TOO-moo-mab) drug used with gemcitabine and cisplatin to treat squamous non-small cell lung cancer that has spread to other parts of the body. It is used in patients whose cancer has not been treated with any other cancer therapy. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
necitumumab - (pronounced) (NEH-sih-TOO-moo-mab) drug used with gemcitabine and cisplatin to treat squamous non-small cell lung cancer that has spread to other parts of the body. It is used in patients whose cancer has not been treated with any other cancer therapy. It is also being studied in the treatment of other types of cancer. Necitumumab attaches to a protein called epidermal growth factor receptor (EGFR), which is found on some types of cancer cells. Blocking this protein can help prevent cancer cells from growing. Necitumumab is a type of monoclonal antibody. Also called Portrazza
External links
- Medical encyclopedia article on Necitumumab
- Wikipedia's article - Necitumumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski